MyHealthChecked
PLC
("MyHealthChecked" or the "Company")
Notice of
Results
MyHealthChecked PLC (AIM: MHC), the
consumer home-testing healthcare company, will announce its final results for the year ended 31 December
2023 on Tuesday 4 June 2024.
Investor presentation
Penny McCormick, Chief Executive Officer, Lesley Innes, Chief Finance
Officer, and Adam Reynolds, Non-executive Chairman will provide a live presentation relating to the final
results via the Investor Meet Company platform
on Tuesday 4 June 2024
at 16:00 BST.
The presentation is open to all
existing and potential shareholders. Questions can be submitted
pre-event via the Investor Meet Company dashboard up until 9:00am
BST the day before the meeting or at any time during the live
presentation. Investors can sign up to Investor Meet Company for
free and add to meet MyHealthChecked PLC via:
https://www.investormeetcompany.com/myhealthchecked-plc/register-investor
Investors who already
follow MyHealthChecked Plc on the
Investor Meet Company platform will automatically be
invited.
For
further information contact:
|
MyHealthChecked plc
|
www.myhealthchecked.com
|
|
Penny
McCormick, Chief Executive
Officer
|
via
Walbrook PR
|
|
|
|
|
SPARK Advisory Partners Limited (NOMAD)
|
Tel: +44
(0)20 3368 3550
|
|
Neil Baldwin / Jade Bayat
|
|
|
|
|
|
Dowgate Capital Limited (Broker)
|
Tel: +44
(0)20 3903 7715
|
|
David Poutney / Nicholas
Chambers
|
|
|
|
|
|
Walbrook PR Ltd (Media & IR)
|
Tel: +44
(0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
|
|
Paul McManus / Alice
Woodings
|
Mob: +44 (0)7980 541 893 /
+44(0)7407 804 654
|
|
|
|
| |
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in
Cardiff, is an AIM-quoted pioneering UK healthcare company focused
on a range of at-home healthcare and wellness tests.
MyHealthChecked
is the umbrella brand of a range of at-home rapid
tests, as well as DNA, RNA and blood sample collection kits which
have been created to support customers on their journeys to
wellness. The tests are lateral-flow self-tests, whilst the sample
collection kits enable the collection of blood, urine, nasal or
mouth swab samples that are analysed in partner laboratories for a
range of biomarkers. The tests have been made available online and
for over-the-counter purchase.
The MyHealthChecked portfolio has
been identified as part of a change in mindset as customers become
more familiar with the concept of accessible healthcare in the
growing at home testing kit market with a focus on accessibility at
the right price, led by UK-based experts.